Paper37540134
Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.
Siegel MJ and 3 others. Radiol Imaging Cancer, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations. Papers, record 37540134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37540134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Male | |
| Response Evaluation Criteria in Solid Tumors | |
| Retrospective Studies |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA091842 | NCI NIH HHS | United States | P30CA091842 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 37540135 | Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations? | https://conductscience.org/library/papers/37540135 |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19097774 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19097774 | PubMed |
| 2 | 19101138 | Lessons learned from independent central review. | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19101138 | PubMed |
| 3 | 24772204 | Automated tracking of quantitative assessments of tumor burden in clinical trials. | Transl Oncol | 2014 | https://conductscience.org/library/papers/24772204 | PubMed |
| 4 | 12829678 | Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12829678 | PubMed |
| 5 | 36780606 | Automatic Classification of Tumor Response From Radiology Reports With Rule-Based Natural Language Processing Integrated Into the Clinical Oncology Workflow. | JCO Clin Cancer Inform | 2023 | https://conductscience.org/library/papers/36780606 | PubMed |
| 6 | 19875758 | Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials. | Ann Oncol | 2010 | https://conductscience.org/library/papers/19875758 | PubMed |
| 7 | 20033179 | RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. | Eur Radiol | 2010 | https://conductscience.org/library/papers/20033179 | PubMed |
| 8 | 10655437 | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/10655437 | PubMed |
| 9 | 22933974 | Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1. | Radiol Oncol | 2012 | https://conductscience.org/library/papers/22933974 | PubMed |
| 10 | 35657292 | Standardized Reporting of Oncologic Response: Making Every Report Count. | Radiol Imaging Cancer | 2022 | https://conductscience.org/library/papers/35657292 | PubMed |
| 11 | 28825135 | Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria. | J Cancer Res Clin Oncol | 2017 | https://conductscience.org/library/papers/28825135 | PubMed |
| 12 | 20397778 | Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria. | Acta Oncol | 2010 | https://conductscience.org/library/papers/20397778 | PubMed |
| 13 | 33059819 | Imaging for Response Assessment in Cancer Clinical Trials. | Semin Nucl Med | 2020 | https://conductscience.org/library/papers/33059819 | PubMed |
| 14 | 23932487 | Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer. | Lung Cancer | 2013 | https://conductscience.org/library/papers/23932487 | PubMed |
| 15 | 26687017 | Observer variability in RECIST-based tumour burden measurements: a meta-analysis. | Eur J Cancer | 2016 | https://conductscience.org/library/papers/26687017 | PubMed |
| 16 | 30537991 | Discrepancies of assessments in a RECIST 1.1 phase II clinical trial - association between adjudication rate and variability in images and tumors selection. | Cancer Imaging | 2018 | https://conductscience.org/library/papers/30537991 | PubMed |
| 17 | 19095437 | Individual patient data analysis to assess modifications to the RECIST criteria. | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19095437 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42761733 | Multicenter AI- versus expert-assisted RECIST target lesion measurements in follow-up body CT of patients with cancer. | Radiol Adv | 2026 | https://conductscience.org/library/papers/42761733 | PubMed |
| 42733787 | Setting the standard: empirical benchmarks for case-level site-central discordance in radiographic endpoints in oncology clinical trials. | Contemp Clin Trials Commun | 2026 | https://conductscience.org/library/papers/42733787 | PubMed |
| 41649544 | [Imaging-based response criteria in oncology : Assessment of response to treatment in solid tumors and lymphomas]. | Radiologie (Heidelb) | 2026 | https://conductscience.org/library/papers/41649544 | PubMed |
| 39543673 | A call for objectivity: Radiologists' proposed wishlist for response evaluation in solid tumors (RECIST 1.1). | Cancer Imaging | 2024 | https://conductscience.org/library/papers/39543673 | PubMed |
| 39123402 | Imaging-Based Disease Assessment and Management Recommendations: Impact of Multidisciplinary Sarcoma Tumor Board. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123402 | PubMed |
| 38473353 | Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473353 | PubMed |
| 37995707 | Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine. | Nuklearmedizin | 2023 | https://conductscience.org/library/papers/37995707 | PubMed |
| 37540135 | Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations? | Radiol Imaging Cancer | 2023 | https://conductscience.org/library/papers/37540135 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37540134
GET https://conductscience.org/api/papers/v1/37540134/authors